Targeting the biotechnology clusters in North Carolina and Israel: Lessons from successful and unsuccessful policy making

Technology Analysis and Strategic Management

Volumn 25, Issue 7, 2013, Pages 835-851

  Avnimelech, Gil ^a  

^a ONO ACADEMIC COLLEGE   (Israel)

Author keywords

biotechnology; business and management studies; case study; clusters; evolutionary economics and technology; historical analysis

Indexed keywords

BIOTECHNOLOGY; BUSINESS; CLUSTER ANALYSIS; MANUFACTURING; POLICY DEVELOPMENT; POLICY MAKING; STRATEGIC APPROACH; TECHNOLOGY POLICY;

ISRAEL; NORTH CAROLINA; UNITED STATES;

EID: 84882288684     PISSN: 09537325     EISSN: 14653990     Source Type: Journal    
DOI: 10.1080/09537325.2013.815710     Document Type: Article

References (46)

1. Aviv, H. 1998. Steering committee for enhancing biotechnology in Israel. Final report submitted to the Ministry of Science and Technology, Israel, January 1998.
2. Avnimelech, G. and Feldman, M. 2010. Regional corporate spawning and the role of Homegrown companies. Review of Policy Research, 27 (4): 475 - 89. (doi:10.1111/j.1541-1338.2010.00452.x)
3. Avnimelech, G. 2008. A five-phase entrepreneurial oriented innovation and technology policy profile: The Israeli experience. European Planning Studies, 16: 81 - 98. (doi:10.1080/09654310701747985)
4. Avnimelech, G. and Teubal, M. 2004. Venture capital - start up co-evolution and the emergence and development of israel's new high tech cluster - Part 1: Macroeconomic and industry analysis. Economics of Innovation and New Technology, 13: 33 - 60. (doi:10.1080/1043859042000156020)
5. Avnimelech, G. and Teubal, M. 2006. Creating venture capital (VC) industries that co-evolve with high tech clusters: Insights from an extended industry life cycle perspective of the Israeli experience. Research Policy, 35: 1477 - 98. (doi:10.1016/j.respol.2006.09.017)
6. Avnimelech, G. and Teubal, M. 2008a. Evolutionary targeting. Journal of Evolutionary Economics, 18: 151 - 66. (doi:10.1007/s00191-007-0080-6)
7. Avnimelech, G. and Teubal, M. 2008b. From direct support of business sector R&D/innovation to targeting venture capital/private equity: A catching-up innovation and technology policy life cycle perspective. Economics of Innovation and New Technology, 17: 153 - 72. (doi:10.1080/10438590701279417)
8. Bowditch, N., S. Budihardjo, P. Schwehm, and J. Van Kirk. 2009. Leadership, partnerships, and networks: Navigating 50 years of dynamic growth in the Research Triangle Park. Paper presented at the XXVI IASP World Conference on Science and Technology Parks, Rayleigh, NC.
9. Cooke, P., Tödtling, F. and Schwartz, D. 2011. " Regional innovation and growth dynamics - introduction ". In Handbook of regional innovation and growth, Edited by: Cooke, P., Asheim, B., Martin, R., Tödtling, F., Boschma, R. and Schwartz, D. Cheltenham: Edward Elgar.
10. directory.ncbiotech.org. (2013). NCBiotech Company Directory. A directory of bioscience companies, related companies and support organizations in North Carolina.
11. DeVol, R., Wong, P., Ki, J., Bedroussian, A. and Koepp, R. 2004. America's biotech and life science clusters. San Diego's position and economic contributions, Santa Monica, CA: Milken Institute.
12. Dutrénit, G., Puchet Anyul, M. and Teubal, M. 2011. Building bridges between co-evolutionary approaches to science, technology and innovation and development economics: An interpretive model. Innovation and Development, 1 (1): 51 - 74. (doi:10.1080/2157930X.2010.551061)
13. Glen, Y. 2008. Accelerating medical solutions in Israel: Building a global life science industry. Paper presented at the Israeli Presidential Conference 2008, Milken Institute, Financial Innovations Lab Report, Vol. 6, May 2008.
14. GlenRock. 2007. The biotechnology industry in Israel - a national missed opportunity. Report submitted to the Chief Scientist at the Ministry of Industry and Trade, Israel, May 2007.
15. Hamdouch, A. 2008. Conceptualizing innovation clusters and networks. University of Lille (available at SSRN 1261972).
16. Hardin, W.J. 2008a. Advancing innovation in North Carolina: An innovation framework for competing and prospering in the interconnected global economy. NC Board of Science and technology, North Carolina, December, 2008.
17. Hardin, W. J. 2008b. " North Carolina's Research Triangle Park: Overview, history, success factors and lessons learned ". In Pathways to High-tech Valleys and Research Triangles: Innovative Entrepreneurship, Knowledge Transfer and Cluster Formation in Europe and the United States, Edited by: Hulsink, W. and Dons, H. 27 - 51. Heidelberg: Springer. ch. 2
18. ILSI. 2013. Israel association of life science industries, Israel (www.ilsi.org.il).
19. IVC. 2013. Israel venture capital research center, Israel (www.ivc-online.co.il).
20. Katzir, A. 1988. Policy to enhance biotechnology R&D in Israel (in Hebrew). The National Biotechnology Committee, Israel.
21. Katzir, A., and M. Herzberg. 1992. Biotechnology progress report (in Hebrew). The National Biotechnology Committee, Israel.
22. Kaufmann, D., Schwartz, D., Frenkel, A. and Shefer, D. 2003. The role of location and regional networks for biotechnology firms in Israel. European Planning Studies, 11: 823 - 40. (doi:10.1080/0965431032000121364)
23. Kaufmann, D. and Schwartz, D. 2008. Networking: The 'missing link' in public R&D support schemes. European Planning Studies, 16: 429 - 40. (doi:10.1080/09654310801920565)
24. Link, A. N. 1995. A generosity of spirit: The early history of the Research Triangle Park, Research Triangle Park, NC: Research Triangle Foundation.
25. Link, A. N. and Scott, J. T. 2003. The growth of Research Triangle Park. Small Business Economics, 20: 167 - 75. (doi:10.1023/A:1022216116063)
26. Meser-Yaron, H. 2001. National priority to biotechnology. Science Ministry Think Tank, Israel.
27. Monitor. 2001. Realizing our potential - Israeli Biotechnology Strategy Project. Report submitted to the Chief Scientist at the Ministry of Industry and Trade, the Ministry of Finance and to Israel Biotechnology Organization, January 2001.
28. NC Board of Science and Technology. 1984. Biotechnolog. Submitted to North Carolina General Assembly, 7 June 1984.
29. NC Board of Science and Technology. 1985. Biotechnology development. Submitted to North Carolina General Assembly, 1 July 1985.
30. NCBC. 1990. Biotechnology in North Carolina: A progress report 1984-1990. North Carolina Biotechnology Center, RTP, NC.
31. NCBC Annual Report 2001. http://www.ncbiotech.org/sites/default/files/01AnnualReport.pdf
32. NCBC Annual Report 2002. http://www.ncbiotech.org/sites/default/files/02AnnualReport.pdf
33. NCBC Annual Report 2003. http://www.ncbiotech.org/sites/default/files/03AnnualReport.pdf
34. NCBC Annual Report 2004. http://www.ncbiotech.org/sites/default/files/04AnnualReport.pdf
35. NCBC Annual Report 2005. http://www.ncbiotech.org/sites/default/files/05AnnualReport.pdf
36. NCBC Annual Report 2006. http://www.ncbiotech.org/sites/default/files/06AnnualReport.pdf
37. NCBC Annual Report 2007. http://www.ncbiotech.org/sites/default/files/07AnnualReport.pdf
38. NCBC Annual Report 2008. http://www.ncbiotech.org/sites/default/files/08AnnualReport.pdf
39. NCBC Annual Report 2009. http://www.ncbiotech.org/sites/default/files/09AnnualReport.pdf
40. Research Triangle Foundation. 1999. Research Triangle Park: The first forty years - an assessment of the impact on the region and the state of the development and operation of one of the nation's most important technology centers, (by Hamer, Siler George Associates, Silver Springs, MD). Research Triangle Park, NC.
41. Research Triangle Regional Partnership. 2012. State of the Research Triangle Region 2012. North Carolina, 24 May 2012.
42. Saxenian, A. 1996. Regional advantage: Culture and competition in Silicon Valley and Route 128, Cambridge, MA: Harvard University Press.
43. Rosiello, A., Avnimelech, G. and Teubal, M. 2010. Towards a systemic and evolutionary framework for venture capital policy. Journal of Evolutionary Economics, 21: 167 - 89. (doi:10.1007/s00191-010-0189-x)
44. Rosiello, A., Avnimelech, G., Mastroeni, M. and Teubal, M. 2013. Evolutionary policy targeting: Towards a conceptual framework for effective policy intervention. Technology Analysis and Strategic Management, 25 000-00 (this issue).
45. Teubal, M., and O. Zlotnick. 2011. Strategic innovation policy. Science, Technology and Economy Program Working Papers Series, STE-WP-44-2011, Technion, Israel - Institute of Technology, Israel.
46. USPTO. 2013. United States Patent and Trademark Office's (USPTO). http://www.uspto.gov/